Neomycin Inhibits the Angiogenic Activity of Fibroblast and Epidermal Growth Factors
- 5 October 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 287 (4) , 870-874
- https://doi.org/10.1006/bbrc.2001.5668
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Neomycin inhibits angiogenin-induced angiogenesisProceedings of the National Academy of Sciences, 1998
- Angiogenesis and Tumor MetastasisAnnual Review of Medicine, 1998
- CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPYPharmacological Research, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Angiogenesis as a Target for Tumor TreatmentOncology, 1997
- Growth factors in angiogenesis: current interest and therapeutic potentialMolecular Medicine Today, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Nuclear Translocation of Angiogenic Proteins in Endothelial Cells: An Essential Step in AngiogenesisBiochemistry, 1994
- Expression of Met-(−1) angiogenin in Escherichia coli: Conversion to the authentic <Glu-1 proteinAnalytical Biochemistry, 1988
- Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cellsBiochemistry, 1985